Leerink Partners analyst Mike Kratky lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $59.00 (from $62.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Tandem Diabetes (TNDM) Tops Q3 EPS by 6c, Beats on Revenue; Offers FY24 Revenue GuidanceNovember 6, 2024 4:40 PM Form 10-Q TANDEM DIABETES CARE For: Sep 30November 6, 2024 4:12 PM Form 8-K TANDEM DIABETES CARE For: Nov 06November 6, 2024 4:09 PM Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales GuidanceNovember 6, 2024 4:05 PM Bernstein SocGen Group Starts Tandem Diabetes Care (TNDM) at OutperformNovember 5, 2024 4:27 PM